Author Correction: Antihypertensive treatment with calcium channel blockers and renal protection: focus on lercanidipine and lercanidipine/enalapril

Eur Rev Med Pharmacol Sci. 2022 Nov;26(22):8204. doi: 10.26355/eurrev_202211_30347.NO ABSTRACTPMID:36459001 | DOI:10.26355/eurrev_202211_30347

Source: Pharmacological Reviews - December 2, 2022 Category: Drugs & Pharmacology Authors: N Ferri A Corsini R Pontremoli Source Type: research